Dental Sleep Medicine Market Report 2026

The dental sleep medicine market size has grown strongly in recent years. It will grow from $6.22 billion in 2025 to $6.65 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to growing recognition of obstructive sleep apnea as a public health issue, limitations of long-term CPAP adherence, early adoption of mandibular advancement devices, increasing role of dentists in sleep disorder screening, expansion of sleep laboratories and diagnostic services.

The dental sleep medicine market size is expected to see strong growth in the next few years. It will grow to $8.69 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to rising prevalence of sleep apnea across age groups, increasing patient preference for non-invasive therapies, growth in aging population with sleep disorders, expanding insurance coverage for oral appliance therapy, increasing integration of dental care into holistic health models. Major trends in the forecast period include rising adoption of oral appliance therapy for sleep apnea, increasing collaboration between dentists and sleep physicians, growing awareness of non-surgical sleep disorder treatments, expansion of dental sleep medicine services in general dentistry, increasing demand for home-based sleep disorder management.

The growing demand for cosmetic dental treatments is expected to drive the expansion of the dental sleep medicine market in the coming years. Cosmetic dental treatments are procedures intended to enhance the appearance of teeth and improve overall smile aesthetics. Demand for these treatments is increasing due to heightened awareness of oral aesthetics, advancements in dental technologies, a stronger emphasis on personal appearance and self-confidence, and broader access to affordable treatment options. The dental sleep medicine market supports cosmetic dentistry by managing sleep-related breathing disorders, reducing bruxism, improving jaw alignment, and supporting long-term oral health, which in turn enhances the durability and effectiveness of cosmetic dental results. For example, in July 2023, according to Dentistry.co.uk, a UK-based dental information platform, one-third of individuals under the age of 35 underwent a cosmetic dental procedure in 2022, with an average expenditure of £3,677 ($4,696.3), while 10% of people aged 25-34 spent £25,000 ($31,930.5) or more. Thus, the rising demand for cosmetic dental treatments is contributing to the growth of the dental sleep medicine market.

Major companies operating in the dental sleep medicine market are concentrating on the development of innovative precision oral appliance therapy (OAT) devices to enhance treatment outcomes and patient comfort. Oral appliance therapy (OAT) devices are custom-made mouthpieces worn during sleep to maintain an open airway and help manage sleep apnea or snoring. For instance, in June 2025, ProSomnus Sleep Technologies Inc., a US-based technology company, introduced an oral appliance named EVO Guided to its FDA-cleared EVO product line, specifically designed to treat obstructive sleep apnea (OSA). The device is designed to increase tongue space and stabilize the jaw in an exact therapeutic position to keep the airway open without limiting tongue movement. Fully customized to individual patient anatomy, EVO Guided provides improved comfort and effectiveness and is covered by most medical insurance plans, including Medicare.

In December 2023, apZme, a US-based sleep and dental management organization, acquired Sleep Impressions for an undisclosed amount. This acquisition enhances apZme’s capabilities in dental sleep medicine by incorporating Sleep Impressions’ specialized expertise in medical billing and coding to simplify reimbursement processes and improve claim accuracy. It also boosts apZme’s operational efficiency by expanding its comprehensive service offerings for dental sleep practices. Sleep Impressions is a US-based company that specializes in medical billing and coding services for dental sleep medicine.

Major companies operating in the dental sleep medicine market are SomnoMed Ltd., ProSomnus Inc., Vivos Therapeutics Inc., Oventus Medical Ltd., Panthera Dental Inc., Myerson LLC, Oral Arts Dental Laboratories Inc., Dental Sleep Solutions LLC, Sleep Group Solutions Inc., Carestream Dental LLC, Henry Schein Inc., Dentsply Sirona, Koninklijke Philips NV, ResMed, Compumedics Limited, Natus Medical Inc., Braebon Medical Corporation, BMC Medical Co. Ltd., Fisher & Paykel Healthcare Limited, ProSomnus Sleep Technologies.

North America was the largest region in the dental sleep medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dental sleep medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dental sleep medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have had a moderate impact on the dental sleep medicine market by increasing the cost of imported oral appliances, diagnostic equipment, and electronic sleep monitoring devices. These effects have been most noticeable in diagnostic and treatment device segments, particularly in North America and Europe where advanced dental sleep equipment is often sourced internationally. Asia-Pacific markets have experienced cost fluctuations due to component imports. However, tariffs have encouraged local manufacturing of dental appliances and regional sourcing of diagnostic tools, supporting supply chain resilience and cost control.

The dental sleep medicine market research report is one of a series of new reports that provides dental sleep medicine market statistics, including dental sleep medicine industry global market size, regional shares, competitors with a dental sleep medicine market share, detailed dental sleep medicine market segments, market trends and opportunities, and any further data you may need to thrive in the dental sleep medicine industry. This dental sleep medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dental sleep medicine is a specialized branch of dentistry dedicated to the identification, treatment, and management of sleep-related disorders, especially obstructive sleep apnea (OSA) and other breathing-associated sleep conditions. Dentists trained in this area utilize oral appliances or devices to help control these disorders. The field focuses on enhancing sleep quality and overall health through non-surgical treatment approaches.

The primary areas of dental sleep medicine include diagnostics and treatment. Dental sleep medicine diagnostics involve oral and dental evaluations used to assess and diagnose sleep disorders, particularly obstructive sleep apnea (OSA). These services are provided across different age groups, including pediatric, adult, and geriatric populations, and are utilized by various end users such as hospitals, sleep laboratories, homes, and others.

The dental sleep medicine market consists of revenues earned by entities by providing services such as sleep apnea screening, sleep studies and diagnostics, treatment planning and consultation and collaborative care. The market value includes the value of related goods sold by the service provider or included within the service offering. The dental sleep medicine market also includes sales of custom oral appliances, replacement parts for oral appliances, sleep tracking devices and comfort accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.